DNAX-activating protein of 12 kDa impairs host defense in pneumococcal pneumonia. 2014

Tijmen J Hommes, and Arie J Hoogendijk, and Mark C Dessing, and Cornelis Van't Veer, and Sandrine Florquin, and Alex F de Vos, and Tom van der Poll
1Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 2Center for Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 3Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 4Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

OBJECTIVE Streptococcus pneumoniae is the most common causative organism in community-acquired pneumonia responsible for millions of deaths every year. DNAX-activating protein of 12 kDa is an adaptor molecule for different myeloid expressed receptors involved in innate immunity. METHODS Animal study. METHODS University research laboratory. METHODS DNAX-activating protein of 12 kDa-deficient (dap12) and wild-type mice. METHODS Mice were intranasally infected with S. pneumoniae. In addition, ex vivo responsiveness of alveolar macrophages was examined. RESULTS dap12 alveolar macrophages released more tumor necrosis factor-α upon stimulation with S. pneumoniae and displayed increased phagocytosis of this pathogen compared with wild-type cells. After infection with S. pneumoniae via the airways, dap12 mice demonstrated reduced bacterial outgrowth in the lungs together with delayed dissemination to distant body sites relative to wild-type mice. This favorable response in dap12 mice was accompanied by reduced lung inflammation and an improved survival. CONCLUSIONS These data suggest that DNAX-activating protein of 12 kDa impairs host defense during pneumococcal pneumonia at the primary site of infection at least in part by inhibiting phagocytosis by alveolar macrophages.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013296 Streptococcus pneumoniae A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals. Diplococcus pneumoniae,Pneumococcus
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D016676 Macrophages, Alveolar Round, granular, mononuclear phagocytes found in the alveoli of the lungs. They ingest small inhaled particles resulting in degradation and presentation of the antigen to immunocompetent cells. Alveolar Macrophages,Macrophages, Pulmonary,Pulmonary Macrophages,Macrophage, Pulmonary,Pulmonary Macrophage,Alveolar Macrophage,Macrophage, Alveolar
D048868 Adaptor Proteins, Signal Transducing A broad category of carrier proteins that play a role in SIGNAL TRANSDUCTION. They generally contain several modular domains, each of which having its own binding activity, and act by forming complexes with other intracellular-signaling molecules. Signal-transducing adaptor proteins lack enzyme activity, however their activity can be modulated by other signal-transducing enzymes Signal Transducing Adaptor Proteins

Related Publications

Tijmen J Hommes, and Arie J Hoogendijk, and Mark C Dessing, and Cornelis Van't Veer, and Sandrine Florquin, and Alex F de Vos, and Tom van der Poll
November 1996, The Journal of infectious diseases,
Tijmen J Hommes, and Arie J Hoogendijk, and Mark C Dessing, and Cornelis Van't Veer, and Sandrine Florquin, and Alex F de Vos, and Tom van der Poll
January 2015, Journal of immunology (Baltimore, Md. : 1950),
Tijmen J Hommes, and Arie J Hoogendijk, and Mark C Dessing, and Cornelis Van't Veer, and Sandrine Florquin, and Alex F de Vos, and Tom van der Poll
June 2012, The Journal of infectious diseases,
Tijmen J Hommes, and Arie J Hoogendijk, and Mark C Dessing, and Cornelis Van't Veer, and Sandrine Florquin, and Alex F de Vos, and Tom van der Poll
May 2012, The Journal of biological chemistry,
Tijmen J Hommes, and Arie J Hoogendijk, and Mark C Dessing, and Cornelis Van't Veer, and Sandrine Florquin, and Alex F de Vos, and Tom van der Poll
April 2009, Journal of immunology (Baltimore, Md. : 1950),
Tijmen J Hommes, and Arie J Hoogendijk, and Mark C Dessing, and Cornelis Van't Veer, and Sandrine Florquin, and Alex F de Vos, and Tom van der Poll
February 2004, The Journal of infectious diseases,
Tijmen J Hommes, and Arie J Hoogendijk, and Mark C Dessing, and Cornelis Van't Veer, and Sandrine Florquin, and Alex F de Vos, and Tom van der Poll
December 2012, Critical care (London, England),
Tijmen J Hommes, and Arie J Hoogendijk, and Mark C Dessing, and Cornelis Van't Veer, and Sandrine Florquin, and Alex F de Vos, and Tom van der Poll
February 1997, American journal of respiratory and critical care medicine,
Tijmen J Hommes, and Arie J Hoogendijk, and Mark C Dessing, and Cornelis Van't Veer, and Sandrine Florquin, and Alex F de Vos, and Tom van der Poll
April 2023, Pathogens (Basel, Switzerland),
Tijmen J Hommes, and Arie J Hoogendijk, and Mark C Dessing, and Cornelis Van't Veer, and Sandrine Florquin, and Alex F de Vos, and Tom van der Poll
March 2015, Critical care medicine,
Copied contents to your clipboard!